Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for antipsychotic-induced acute akathisia
IRCT20250308064978N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in akathisia comparing Pregabalin with Placebo (2 arms). Primary endpoint: Reduction in akathisia severity. Started Apr 2025; status: completed.
02
Drugs
pregabalin
03
Conditions
akathisia
Beyond the preview
Go deeper on IRCT20250308064978N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250308064978N1.